Integrated Two-Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non-Hodgkin Lymphoma.

Saved in:
Bibliographic Details
Title: Integrated Two-Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non-Hodgkin Lymphoma.
Authors: Lu D; Genentech Inc., South San Francisco, California, USA., Lu T; Genentech Inc., South San Francisco, California, USA., Gibiansky L; QuantPharm LLC, North Potomac, Maryland, USA., Li X; Genentech Inc., South San Francisco, California, USA., Li C; Genentech Inc., South San Francisco, California, USA., Agarwal P; Genentech Inc., South San Francisco, California, USA., Shemesh CS; Genentech Inc., South San Francisco, California, USA., Shi R; Genentech Inc., South San Francisco, California, USA., Dere RC; Genentech Inc., South San Francisco, California, USA., Hirata J; Genentech Inc., South San Francisco, California, USA., Miles D; Genentech Inc., South San Francisco, California, USA., Chanu P; Genentech/Roche, Lyon, France., Girish S; Genentech Inc., South San Francisco, California, USA., Jin JY; Genentech Inc., South San Francisco, California, USA.
Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2020 Jan; Vol. 9 (1), pp. 48-59. Date of Electronic Publication: 2019 Dec 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first